98 related articles for article (PubMed ID: 22537621)
1. Peroxiredoxins and tropomyosins as plasma biomarkers for lung cancer and asbestos exposure.
Rostila A; Puustinen A; Toljamo T; Vuopala K; Lindström I; Nyman TA; Oksa P; Vehmas T; Anttila SL
Lung Cancer; 2012 Aug; 77(2):450-9. PubMed ID: 22537621
[TBL] [Abstract][Full Text] [Related]
2. High association of peroxiredoxins with lung cancer.
Soini Y; Kinnula VL
Lung Cancer; 2012 Nov; 78(2):167. PubMed ID: 22981900
[No Abstract] [Full Text] [Related]
3. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species-regulating proteins peroxiredoxin 2 and thioredoxin, and glyceraldehyde-3-phosphate dehydrogenase are differentially abundant in induced sputum from smokers with lung cancer or asbestos exposure.
Rostila AM; Anttila SL; Lalowski MM; Vuopala KS; Toljamo TI; Lindström I; Baumann MH; Puustinen AM
Eur J Cancer Prev; 2020 May; 29(3):238-247. PubMed ID: 31567534
[TBL] [Abstract][Full Text] [Related]
5. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
Nelson HH; Christiani DC; Wiencke JK; Mark EJ; Wain JC; Kelsey KT
Cancer Res; 1999 Sep; 59(18):4570-3. PubMed ID: 10493509
[TBL] [Abstract][Full Text] [Related]
6. Clinical study of asbestos-related lung cancer in Japan with special reference to occupational history.
Kishimoto T; Gemba K; Fujimoto N; Onishi K; Usami I; Mizuhashi K; Kimura K
Cancer Sci; 2010 May; 101(5):1194-8. PubMed ID: 20331622
[TBL] [Abstract][Full Text] [Related]
7. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk.
Schabath MB; Spitz MR; Delclos GL; Gunn GB; Whitehead LW; Wu X
Am J Ind Med; 2002 Jul; 42(1):29-37. PubMed ID: 12111688
[TBL] [Abstract][Full Text] [Related]
8. Assessment of biomarkers in asbestos-exposed workers as indicators of cancer risk.
Amati M; Tomasetti M; Mariotti L; Tarquini LM; Valentino M; Santarelli L
Mutat Res; 2008; 655(1-2):52-8. PubMed ID: 18638565
[TBL] [Abstract][Full Text] [Related]
9. Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers.
Ali IU; Xiao Z; Malone W; Smith M; Conrads TP; Veenstra TD; Greenwald P; Luke BT; McLarty JW
Oncol Rep; 2006 May; 15(5):1367-72. PubMed ID: 16596212
[TBL] [Abstract][Full Text] [Related]
10. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer.
Kettunen E; Salmenkivi K; Vuopala K; Toljamo T; Kuosma E; Norppa H; Knuutila S; Kaleva S; Huuskonen MS; Anttila S
Lung Cancer; 2006 Nov; 54(2):169-76. PubMed ID: 16935392
[TBL] [Abstract][Full Text] [Related]
11. Augmented expression of peroxiredoxin I in lung cancer.
Chang JW; Jeon HB; Lee JH; Yoo JS; Chun JS; Kim JH; Yoo YJ
Biochem Biophys Res Commun; 2001 Nov; 289(2):507-12. PubMed ID: 11716502
[TBL] [Abstract][Full Text] [Related]
12. ADAM28: a potential oncogene involved in asbestos-related lung adenocarcinomas.
Wright CM; Larsen JE; Hayward NK; Martins MU; Tan ME; Davidson MR; Savarimuthu SM; McLachlan RE; Passmore LH; Windsor MN; Clarke BE; Duhig EE; Yang IA; Bowman RV; Fong KM
Genes Chromosomes Cancer; 2010 Aug; 49(8):688-98. PubMed ID: 20544843
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
Gamble JF; Gibbs GW
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
[TBL] [Abstract][Full Text] [Related]
14. [Asbestos and risk of cancer: exposure-effect relationships for occupationally exposed populations].
Goldberg M
Rev Mal Respir; 1999 Dec; 16(6 Pt 2):1278-85. PubMed ID: 10897849
[TBL] [Abstract][Full Text] [Related]
15. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
[TBL] [Abstract][Full Text] [Related]
16. Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos.
Gube M; Taeger D; Weber DG; Pesch B; Brand P; Johnen G; Müller-Lux A; Gross IM; Wiethege T; Weber A; Raithel HJ; Kraus T; Brüning T
Arch Toxicol; 2011 Mar; 85(3):185-92. PubMed ID: 20737138
[TBL] [Abstract][Full Text] [Related]
17. Occupational asbestos exposure among respiratory cancer patients in Lithuania.
Everatt RP; Smolianskiene G; Tossavainen A; Cicenas S; Jankauskas R
Am J Ind Med; 2007 Jun; 50(6):455-63. PubMed ID: 17497698
[TBL] [Abstract][Full Text] [Related]
18. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry.
Li DQ; Wang L; Fei F; Hou YF; Luo JM; ; Zeng R; Wu J; Lu JS; Di GH; Ou ZL; Xia QC; Shen ZZ; Shao ZM
Proteomics; 2006 Jun; 6(11):3352-68. PubMed ID: 16637015
[TBL] [Abstract][Full Text] [Related]
19. [Asbestos fibre lung burden and exposure indices in asbestos-cement workers].
Barbieri PG; Somigliana A; Lombardi S; Girelli R; Benvenuti A
Med Lav; 2009; 100(1):21-8. PubMed ID: 19263869
[TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
